Semaglutide: observed

146 studies: patients on it are followed, or it is given outside a trial. Page 2 of 2. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With MetforminTerminatedNCT06333080Report a problem
• Special Use - Results Surveillance on Long-term Use With Wegovy®Active, not recruitingNCT06283667Report a problem
• SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in HungaryCompletedNCT06269120Report a problem
• Semaglutide and Preoperative Residual Gastric VolumesCompletedNCT06263595Report a problem
• Semaglutide and Physical Activity for Obesity and MultimorbidityActive, not recruitingNCT06234111Report a problem
• Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional StudyCompletedNCT06154486Report a problem
• Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes SubtypesCompletedNCT06120556Report a problem
• Semaglutide Use in Acute Pulmonary EmbolismCompletedNCT06118203Report a problem
• SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®CompletedNCT05897398Report a problem
• Anti-obesity Pharmacotherapy and InflammationActive, not recruitingNCT05756764Report a problem
• DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in ItalyCompletedNCT05755360Report a problem
• O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and KuwaitCompletedNCT05716724Report a problem
• Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)Active, not recruitingNCT05622045Report a problem
• Prediction of the SEPRA Diabetes Trial in Healthcare Claims DataCompletedNCT05577728Report a problem
• A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in IndiaCompletedNCT05502562Report a problem
• Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental HealthStatus unknownNCT05492305Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical PracticeWithdrawnNCT05473286Report a problem
• A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)CompletedNCT05468632Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical PracticeCompletedNCT05443568Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT05443334Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical PracticeCompletedNCT05443191Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical PracticeCompletedNCT05316662Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT05230615Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical PracticeCompletedNCT05230589Report a problem
• Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes StudyActive, not recruitingNCT05220917Report a problem
• SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.CompletedNCT05136287Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical PracticeCompletedNCT04878393Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical PracticeCompletedNCT04862923Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical PracticeCompletedNCT04601753Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical PracticeCompletedNCT04601740Report a problem
• Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataCompletedNCT04572165Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical PracticeCompletedNCT04559815Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical PracticeCompletedNCT04537637Report a problem
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical PracticeCompletedNCT04537624Report a problem
• Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®CompletedNCT04469855Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)CompletedNCT04261933Report a problem
• Semaglutide vs Dulaglutide on Epicardial Adipose TissueCompletedNCT04200625Report a problem
• Real-world Health Outcomes in Canadian Patients Using SemaglutideCompletedNCT04175665Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT04094415Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)CompletedNCT04083820Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT04067999Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)CompletedNCT03929679Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)CompletedNCT03876015Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)CompletedNCT03648281Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)CompletedNCT03631186Report a problem
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical PracticeCompletedNCT03457012Report a problem

← Semaglutide